Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

DLS Instrument

By Drug Discovery Trends Editor | February 17, 2009

Wyatt's DynoPro NanoStarWyatt Technology Corporation unveiled its new Dynamic Light Scattering (DLS) instrument – the DynaPro NanoStar – at booth #4386 at Pittcon 2009. The Wyatt NanoStar is a DLS designed to deliver optimum versatility and stability to ensure consistently high performance.

With emphasis on innovation, the Wyatt NanoStar features a dedicated Static Light Scattering detector so it can measure not only hydrodynamic radii, but also absolute molecular weights. The instrument also has a TCP/IP interface, to allow it to be added to a laboratory network instantly and operated from anywhere with an Internet connection.

The temperature control built-in provides fast response times and wide temperature range (from 4?C to 150?C). The Nanostar offers precise temperature control, with a stability of better than 0.01?C over the entire range, and a proprietary thermal design that can change temperatures as quickly as 15?C/min. When operating below ambient temperatures, the NanoStar employs a dual valve dry nitrogen flow that keeps the cell dry and dust free.

Its air-launched laser, coupled with proprietary optics for higher sensitivity, make single mode optical fiber technology obsolete. The NanoStar’s multi-mode fibers collect a larger fraction of the scattered light, which gives better performance for weakly scattering samples. With higher sensitivity, the NanoStar also detects trace amounts of aggregation that other DLS instruments may miss, according to Wyatt.

A double density correlator is standard, which has 512 bins from 100 nsec to one hour, and instead of having 16 bins in the first stage and eight in each subsequent stage, the NanoStar has 32 in the first stage and 16 in the higher stages. In order to ensure that the NanoStar never goes out of range, it comes equipped with automatic attenuation over five orders of magnitude.

Non-perturbing and non-destructive, the NanoStar determines the hydrodynamic radius and absolute molecular weight of nanoparticles simultaneously. With this information, the NanoStar provides unique insights beyond those obtained from conventional DLS technologies, opening new frontiers for any organization. The NanoStar can also be coupled with Wyatt’s on-line multi-angle light scattering systems (DAWN and miniDAWN) for enhanced resolution of HPLC eluents.

To find out more about the NanoStar visit Wyatt Technology at booth #4386 at Pittcon 2009.

www.wyatt.com


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE